The novel treatment of the medication represents a exciting development in the handling of type 2 diabetes. Distinct from existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide573977.blogminds.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-38892084